Home > Healthcare > Medical Devices > Surgical Devices > Atherectomy Devices Market

Atherectomy Devices Market Trends

Report ID: GMI2769
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Atherectomy Devices Market Trends

In recent years, the treatment for lower extremity peripheral vascular diseases has evolved due to the rising advancements in percutaneous revascularization. Several modern devices are witnessing increased patient interest for treating infrapopliteal and femoropopliteal diseases. These advanced devices integrate technologies, including plaque excisional atherectomy, laser catheters, drug-eluting stents, mechanical thrombectomy, and cryoplasty. The increasing R&D efforts led by prominent industry players for developing innovative and highly advanced products will also create novel atherectomy devices market growth opportunities.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of atherectomy devices was valued at USD 660 million in 2022 and is expected to register over 7% CAGR during 2023 to 2032 owing to the high patient preference for minimally invasive procedures.

The demand for orbital atherectomy devices amassed more than USD 204 million in 2022 and is anticipated to grow at steady pace through 2032 due to their increasing use in minimally invasive procedures for their several clinical benefits.

North America atherectomy devices industry is estimated to be worth USD 865 million by 2032 attributed to the presence of prominent market participants and the higher number of patients suffering from PAD.

Some of the renowned atherectomy devices manufacturers are include Medtronic plc, Avinger, Boston Scientific, Cardiovascular Systems, Inc., Koninklijke Philips N.V, Abbott Laboratories, AngioDynamics Inc., Becton, Dickinson and Company, Terumo Corporation, Cardinal Health Inc., Nipro Corporation, Biomerics LLC and Rex Medical